A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/327 (2006.01) A61K 31/122 (2006.01) A61K 33/40 (2006.01) A61P 1/02 (2006.01)
Patent
CA 2571569
A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide ("DMSO"); a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used effectively to stimulate periapical bone regeneration and for the endodontic treatment of periapical bone abscess, and fibromas, in a patient.
La présente invention concerne une préparation pharmaceutique et son utilisation. Cette préparation pharmaceutique contient des espèces peroxidiques ou des produits de réaction résultant de l'oxydation d'un alkène, tel qu'un géraniol, par un agent d'oxydation contenant de l'oxygène, tel que de l'ozone, un solvant pénétrant, tel qu'un diméthylesulfoxyde (<= 2DMSO >=), un colorant contenantun métal chélaté, tel qu'une hématoporphyrine et, un composé redox aromatique, tel qu'une benzoquinone. Cette préparation pharmaceutique est utilisée efficacement pour stimuler la régénération osseuse périapical et pour le traitement endodontique d'abcès osseux périapical et de fibromes chez un patient.
Hofmann Robert F.
Kirby Eades Gale Baker
Torquin Llc
LandOfFree
Use of targeted oxidative therapeutic formulation in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of targeted oxidative therapeutic formulation in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of targeted oxidative therapeutic formulation in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1921988